Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice : Analysis of a swiss cohort
- Author
- SIMON, Dagmar1 ; LÜBBE, Jann2 ; GILGEN BOBALJ, Nicole9 ; SCHNEIDER, Dirk10 ; WÜTHRICH, Brunello3 ; WIESNER, Alice4 ; MONIKA WEBER, M5 ; LAFFITTE, Emmanuel6 ; ANLIKER, Mark D7 ; SCHÖNI, Martin H8 ; BRAATHEN, Lasse R1 ; SCHMID-GRENDELMEIER, Peter3
[1] Department of Dermatology, University Hospital Bern, Bern, Switzerland
[2] Department of Dermatology, University Hospital Geneva, Geneva, Switzerland
[3] Allergy Unit, Department of Dermatology, University Hospital Zürich, Switzerland
[4] Department of Allergology, Zürich University Children's Hospital, Zürich, Switzerland
[5] Division of Dermatology, University Hospital Basel, Basel, Switzerland
[6] Division of Dermatology, CHUV, Lausanne, Switzerland
[7] Department of Dermatology/Allergy, Cantonal Hospital, St. Gallen, Switzerland
[8] Department of Pediatrics, University Children's Hospital Bern, Switzerland
[9] Novartis Pharma Schweiz AG, Bern, Switzerland
[10] Novartis Pharma AG, Basel, Switzerland - Source
Dermatology (Basel). 2006, Vol 213, Num 4, pp 313-318, 6 p ; ref : 23 ref
- ISSN
- 1018-8665
- Scientific domain
- Dermatology
- Publisher
- Karger, Basel
- Publication country
- Switzerland
- Document type
- Article
- Language
- English
- Author keyword
- Atopic dermatitis Eczema Elidel Pimecrolimus cream 1%
- Keyword (fr)
- Conduite à tenir Crème Dermatite atopique Dermatologie Eczéma Etude cohorte Immunodépresseur Pimécrolimus Pratique professionnelle Traitement Utilisation Allergie Atopie Immunopathologie Inhibiteur synthèse protéique Macrolide Peau pathologie
- Keyword (en)
- Clinical management Cream Atopic dermatitis Dermatology Eczema Cohort study Immunosuppressive agent Pimecrolimus Professional practice Treatment Use Allergy Atopy Immunopathology Protein synthesis inhibitor Macrolide Skin disease
- Keyword (es)
- Actitud médica Crema Dermatitis atópica Dermatología Eczema Estudio cohorte Inmunodepresor Pimecrolimús Práctica profesional Tratamiento Uso Alergia Atopía Inmunopatología Inhibidor síntesis proteica Macrólido Piel patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B06 Immunopathology / 002B06C Allergic diseases / 002B06C04 Skin allergic diseases. Stinging insect allergies
- Discipline
- Dermatology Immunopathology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18348665
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1159/000096195 
https://dx.doi.org/10.1159/000096195
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1159\/000096195\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:144:\"Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice : Analysis of a swiss cohort\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Dermatology (Basel)\";s:9:\"\u0000*\u0000stitle\";s:19:\"Dermatology (Basel)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"213\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"313\";s:8:\"\u0000*\u0000epage\";s:3:\"318\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1018-8665\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"SIMON\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Dagmar\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:12:\"L\u00dcBBE, Jann\";i:1;s:21:\"GILGEN BOBALJ, Nicole\";i:2;s:15:\"SCHNEIDER, Dirk\";i:3;s:19:\"W\u00dcTHRICH, Brunello\";i:4;s:14:\"WIESNER, Alice\";i:5;s:15:\"MONIKA WEBER, M\";i:6;s:18:\"LAFFITTE, Emmanuel\";i:7;s:15:\"ANLIKER, Mark D\";i:8;s:17:\"SCH\u00d6NI, Martin H\";i:9;s:17:\"BRAATHEN, Lasse R\";i:10;s:26:\"SCHMID-GRENDELMEIER, Peter\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:144:\"Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice : Analysis of a swiss cohort\";s:8:\"\u0000*\u0000place\";s:5:\"Basel\";s:6:\"\u0000*\u0000pub\";s:6:\"Karger\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1159\/000096195\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:144:\"Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice : Analysis of a swiss cohort\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Dermatology (Basel)\";s:9:\"\u0000*\u0000stitle\";s:19:\"Dermatology (Basel)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"213\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"313\";s:8:\"\u0000*\u0000epage\";s:3:\"318\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1018-8665\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"SIMON\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Dagmar\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:12:\"L\u00dcBBE, Jann\";i:1;s:21:\"GILGEN BOBALJ, Nicole\";i:2;s:15:\"SCHNEIDER, Dirk\";i:3;s:19:\"W\u00dcTHRICH, Brunello\";i:4;s:14:\"WIESNER, Alice\";i:5;s:15:\"MONIKA WEBER, M\";i:6;s:18:\"LAFFITTE, Emmanuel\";i:7;s:15:\"ANLIKER, Mark D\";i:8;s:17:\"SCH\u00d6NI, Martin H\";i:9;s:17:\"BRAATHEN, Lasse R\";i:10;s:26:\"SCHMID-GRENDELMEIER, Peter\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:144:\"Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice : Analysis of a swiss cohort\";s:8:\"\u0000*\u0000place\";s:5:\"Basel\";s:6:\"\u0000*\u0000pub\";s:6:\"Karger\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:17:\"10.1159\/000096195\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1159\/000096195\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:144:\"Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice : Analysis of a swiss cohort\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Dermatology (Basel)\";s:9:\"\u0000*\u0000stitle\";s:19:\"Dermatology (Basel)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"213\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"313\";s:8:\"\u0000*\u0000epage\";s:3:\"318\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1018-8665\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"SIMON\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Dagmar\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:12:\"L\u00dcBBE, Jann\";i:1;s:21:\"GILGEN BOBALJ, Nicole\";i:2;s:15:\"SCHNEIDER, Dirk\";i:3;s:19:\"W\u00dcTHRICH, Brunello\";i:4;s:14:\"WIESNER, Alice\";i:5;s:15:\"MONIKA WEBER, M\";i:6;s:18:\"LAFFITTE, Emmanuel\";i:7;s:15:\"ANLIKER, Mark D\";i:8;s:17:\"SCH\u00d6NI, Martin H\";i:9;s:17:\"BRAATHEN, Lasse R\";i:10;s:26:\"SCHMID-GRENDELMEIER, Peter\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:144:\"Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice : Analysis of a swiss cohort\";s:8:\"\u0000*\u0000place\";s:5:\"Basel\";s:6:\"\u0000*\u0000pub\";s:6:\"Karger\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1159\/000096195\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:144:\"Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice : Analysis of a swiss cohort\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Dermatology (Basel)\";s:9:\"\u0000*\u0000stitle\";s:19:\"Dermatology (Basel)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"213\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"313\";s:8:\"\u0000*\u0000epage\";s:3:\"318\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1018-8665\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"SIMON\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Dagmar\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:12:\"L\u00dcBBE, Jann\";i:1;s:21:\"GILGEN BOBALJ, Nicole\";i:2;s:15:\"SCHNEIDER, Dirk\";i:3;s:19:\"W\u00dcTHRICH, Brunello\";i:4;s:14:\"WIESNER, Alice\";i:5;s:15:\"MONIKA WEBER, M\";i:6;s:18:\"LAFFITTE, Emmanuel\";i:7;s:15:\"ANLIKER, Mark D\";i:8;s:17:\"SCH\u00d6NI, Martin H\";i:9;s:17:\"BRAATHEN, Lasse R\";i:10;s:26:\"SCHMID-GRENDELMEIER, Peter\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:144:\"Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice : Analysis of a swiss cohort\";s:8:\"\u0000*\u0000place\";s:5:\"Basel\";s:6:\"\u0000*\u0000pub\";s:6:\"Karger\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1159\/000096195\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:144:\"Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice : Analysis of a swiss cohort\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Dermatology (Basel)\";s:9:\"\u0000*\u0000stitle\";s:19:\"Dermatology (Basel)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"213\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"313\";s:8:\"\u0000*\u0000epage\";s:3:\"318\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1018-8665\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"SIMON\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Dagmar\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:12:\"L\u00dcBBE, Jann\";i:1;s:21:\"GILGEN BOBALJ, Nicole\";i:2;s:15:\"SCHNEIDER, Dirk\";i:3;s:19:\"W\u00dcTHRICH, Brunello\";i:4;s:14:\"WIESNER, Alice\";i:5;s:15:\"MONIKA WEBER, M\";i:6;s:18:\"LAFFITTE, Emmanuel\";i:7;s:15:\"ANLIKER, Mark D\";i:8;s:17:\"SCH\u00d6NI, Martin H\";i:9;s:17:\"BRAATHEN, Lasse R\";i:10;s:26:\"SCHMID-GRENDELMEIER, Peter\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:144:\"Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice : Analysis of a swiss cohort\";s:8:\"\u0000*\u0000place\";s:5:\"Basel\";s:6:\"\u0000*\u0000pub\";s:6:\"Karger\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
